Fact CheckerSign in

NCT06883734Completed

The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia

The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia on Engulfment, Quality of Life and Illness Management and Recovery Levels

Source: ClinicalTrials.gov · Last updated 21 Mar 2025

Brief summary (registry, in English)

This study was aimed to examine the effectiveness (illness management and recovery, engulfment, quality of life) of a 12-week the Illness Management Skills Training applied to patients with schizophrenia. The main questions it aims to answer are: Hypothesis (H1-1): Illness Management Skills Training applied intervention group has lower engulfment than the control group. Hypothesis (H1-2): Illness Management Skills Training applied intervention group has higher quality of life than the control group. Hypothesis (H1-3): Illness Management Skills Training applied intervention group has higher illness management and recovery level than the control group. Researchers were compared the Illness Management Skills Training to a control group (no intervention) to see if the Illness Management Skills Training works on engulfment, quality of life, illness management and recovery in patients with schizophrenia. Participants were: \- attended the Illness Management Skills Training, one session per week for 12 weeks, 60 minutes per session, in addition to routine outpatient clinic check-ups.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
13 Mar 2025
Start date
15 Aug 2024
Primary completion date
31 Jan 2025
Lead sponsor
Neslihan Lok
NCT number
NCT06883734

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 15 Aug 2024 to the primary completion date, 31 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having an organic mental disorder or mental retardation,
  • Having a visual or hearing impairment,

Other

  • Participating in a program similar to the intervention to be implemented.

Who the study is looking for

  • Being between the ages of 18-65,
  • Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
  • Being registered with the Selcuk University Faculty of Medical Hospital Mental Health and Diseases Polyclinic,
  • Coming to the polyclinic for regular check-ups,
  • Getting a mild/moderate score from the Positive and Negative Syndrome Scale (PANSS),
  • Taking medication regularly,
  • Being at least literate.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Selcuk University Faculty of Medical Hospital
Coordinator of this site? Confirm its status
KonyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.